Inactive Instrument

Insiders Correvio Pharma Corp Toronto S.E.

Equities

Mark Corrigan Departs as CEO from Correvio Pharma Corp	20-05-27	CI
Correvio Pharma Corp. Announces Management Changes	20-05-27	CI
Correvio Pharma Corp. Approves Appointment of W. James O'Shea as Director	19-06-18	CI
Correvio Pharma Corp. Announces Management Changes	19-03-13	CI
Correvio Pharma Corp Announces Executive Changes	19-01-02	CI
Cardiome Pharma Corp. Announces Management Changes	17-05-16	CI
Cardiome Pharma Corp. Announces Management Appointments	16-08-08	CI
Cardiome Pharma Corp. Announces Addition of Robert James Meyer to Board of Directors	15-09-08	CI
Cardiome Pharma Corp. Announces Executive Appointments	15-06-24	CI
Cardiome Pharma Corp. Appoints David Dean as Vice President, Business Development and Investor Relations	15-06-03	CI
Cardiome Pharma Announces Nomination of W. James O'Shea to Board of Directors	14-06-10	CI
Cardiome Pharma Appoints Jürgen Polifka, Ph.D., as General Manager, Sales and Marketing Europe	13-04-02	CI
Cardiome Pharma Corp. Adds Dr. Steen Juul-Möller as Medical Director, Europe	13-03-28	CI
Cardiome Pharma Corp. Announces Changes in Senior Management Team	13-03-26	CI
Cardiome Pharma Corp. Appoints Jennifer Archibald as Chief Financial Officer	12-09-20	CI
Cardiome Pharma Corp. Announces Management Change	12-07-03	CI

No results for this search